426 related articles for article (PubMed ID: 18644442)
1. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
2. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
3. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
5. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
6. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
[TBL] [Abstract][Full Text] [Related]
8. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.
Damian F; Blaton N; Naesens L; Balzarini J; Kinget R; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2000; 10(4):311-22. PubMed ID: 10838021
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
[TBL] [Abstract][Full Text] [Related]
11. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
12. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods.
Chen YC; Ho HO; Chiou JD; Sheu MT
Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
14. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
15. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
16. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
Dugar RP; Gajera BY; Dave RH
AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
[TBL] [Abstract][Full Text] [Related]
17. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of solid dispersion of furosemide with TPGS.
Shin SC; Kim J
Int J Pharm; 2003 Jan; 251(1-2):79-84. PubMed ID: 12527177
[TBL] [Abstract][Full Text] [Related]
19. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.
Damian F; Blaton N; Kinget R; Van den Mooter G
Int J Pharm; 2002 Sep; 244(1-2):87-98. PubMed ID: 12204568
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
Chen J; Qiu L; Hu M; Jin Y; Han J
Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
